Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:24638167  

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Marie-Luise Berres | Karen Phaik Har Lim | Tricia Peters | Jeremy Price | Hitoshi Takizawa | Hélène Salmon | Juliana Idoyaga | Albert Ruzo | Philip J Lupo | M John Hicks | Albert Shih | Stephen J Simko | Harshal Abhyankar | Rikhia Chakraborty | Marylene Leboeuf | Monique Beltrão | Sérgio A Lira | Kenneth M Heym | Venetia Bigley | Matthew Collin | Markus G Manz | Kenneth McClain | Miriam Merad | Carl E Allen
The Journal of experimental medicine | 2014

Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized by the accumulation of CD207(+) dendritic cells (DCs) in inflammatory lesions. Recurrent BRAF-V600E mutations have been reported in LCH. In this study, lesions from 100 patients were genotyped, and 64% carried the BRAF-V600E mutation within infiltrating CD207(+) DCs. BRAF-V600E expression in tissue DCs did not define specific clinical risk groups but was associated with increased risk of recurrence. Strikingly, we found that patients with active, high-risk LCH also carried BRAF-V600E in circulating CD11c(+) and CD14(+) fractions and in bone marrow (BM) CD34(+) hematopoietic cell progenitors, whereas the mutation was restricted to lesional CD207(+) DC in low-risk LCH patients. Importantly, BRAF-V600E expression in DCs was sufficient to drive LCH-like disease in mice. Consistent with our findings in humans, expression of BRAF-V600E in BM DC progenitors recapitulated many features of the human high-risk LCH, whereas BRAF-V600E expression in differentiated DCs more closely resembled low-risk LCH. We therefore propose classification of LCH as a myeloid neoplasia and hypothesize that high-risk LCH arises from somatic mutation of a hematopoietic progenitor, whereas low-risk disease arises from somatic mutation of tissue-restricted precursor DCs.

Pubmed ID: 24638167

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA154489
  • Agency: NCI NIH HHS, United States
    Id: R01 CA154947
  • Agency: NCI NIH HHS, United States
    Id: R01 CA161373
  • Agency: NCI NIH HHS, United States
    Id: P30 CA125123
  • Agency: NCI NIH HHS, United States
    Id: R01 CA154947A
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI089987
  • Agency: NCI NIH HHS, United States
    Id: K12 CA090433
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI095611
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI10008
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM088129
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI089987
  • Agency: NCI NIH HHS, United States
    Id: P50 CA126752
  • Agency: NCI NIH HHS, United States
    Id: P50CA126752

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BioLegend (tool)

RRID:SCR_001134

Commercial antibody supplier and developer for biomedical research. These products are compatible with use in flow cytometry and mass cytometry, immunoprecipitation and chip, western blotting, immunofluorescence microscopy, and quantitative multiplexing.

View all literature mentions

HEK293 (tool)

RRID:CVCL_0045

Cell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

A-375 (tool)

RRID:CVCL_0132

Cell line A-375 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions